Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RDY · against 141 other Healthcare companies of similar size
Ranked #128 of 142 · scores higher than 9% of peers
Bars: peers in each 10-point band of the growth score11 peers with a growth score of 20–29, including RDY · Click a bar to see the companies
Mainly because of its earnings per share growth, which is weaker than most Healthcare peers.
| Metric | RDY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 143 reported | 3.2% | 10.2% | 20% | 33% | |
| Earnings per share growthHigher is better · 104 reported | -62.1% | 14.1% | 7% | 33% | |
| 3-year revenue growthHigher is better · 137 reported | 11.0% | 10.9% | 51% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 21.4B USD | 97 | 67 | |
| 3 | 7.3B USD | 97 | 74 | |
| 125 | 6.7B USD | 30 | 19 | |
| 126 | 16.9B USD | 29 | 37 | |
| 126 | 18.2B USD | 29 | 40 | |
| 128 | 8.6B USD | 28 | 30 | |
| 128 | 11.9B USD | 28 | 53 | |
| 130 | 12.7B AUD (≈$8.4B) | 27 | 38 | |
| 131 | 1.85T JPY (≈$12.5B) | 26 | 55 | |
| 131 | 21.7B USD | 26 | 32 | |
| 133 | 10.0B USD | 25 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score